News - Appointments

Ablynx NV, a Belgian company that produces a novel class of therapeutic proteins based on single domain antibody fragments, has appointed Josefin-Beate Holz to the newly created position of chi

Bob Hartmayer will become Business Group Director of DSM Pharmaceutical Products on 1 January 2008. He is presently director of DSM Elastomers.

Jado Technologies of Dresden has appointed Charl van Zyl as its new chief executive officer, effective 4 September 2007.

John Hutchison has announced plans to leave his position as development director of Vernalis Plc to join another company in the life sciences sector.

Egalet A/S, a Danish company that has developed technology for the controlled release of drugs through gradual erosion of a tablet, said it has appointed Peter Nordkild as chief executive offic

TheraGenetics Ltd, which produces gene-based tests for establishing the likelihood of a patient responding to a drug or of experiencing side effects, has appointed Heiner Dreismann as chairman.

Probiodrug AG, a developer of small molecule inhibitors against inflammatory and neurodegenerative diseases, has appointed Hendrik Liebers as its chief financial officer, following a round of new f

The European Medicine Agency’s main scientific committee, the Committee for Medicinal Products for Human Use (CHMP), has elected a new chairman and vice chairman for three-year terms, sta

Sareum Holdings Plc has appointed Giorgio Reggiani as finance director following the retirement of Edward Oliver.

Aisling Burnand, chief executive of the BioIndustry Association (BIA) in Britain, has been named a Member of The Order of the British Empire (MBE) for her services to science.